Literature DB >> 34249623

A subregion-based positron emission tomography/computed tomography (PET/CT) radiomics model for the classification of non-small cell lung cancer histopathological subtypes.

Hui Shen1, Ling Chen1, Kanfeng Liu2, Kui Zhao2, Jingsong Li1, Lijuan Yu3, Hongwei Ye4, Wentao Zhu1.   

Abstract

BACKGROUND: This study classifies lung adenocarcinoma (ADC) and squamous cell carcinoma (SCC) using subregion-based radiomics features extracted from positron emission tomography/computed tomography (PET/CT) images.
METHODS: In this study, the standard 18F-fluorodeoxyglucose (FDG) PET/CT images of 150 patients with lung ADC and 100 patients with SCC were retrospectively collected from the PET Center of the First Affiliated Hospital, College of Medicine, Zhejiang University. First, the 3D feature vector of each tumor voxel (whose basis is PET value, CT value, and CT local dominant orientation) was extracted. Using K-means individual clustering and population clustering, each tumor was divided into 4 subregions that reflect intratumoral regional heterogeneity. Next, based on each subregion, 385 radiomics features were extracted. Clinical features including age, gender, and smoking history were included. Thus, there were a total of 1,543 features extracted from PET/CT images and clinical reports. Statistical tests were then used to eliminate irrelevant and redundant features, and the recursive feature elimination (RFE) algorithm was used to select the best feature subset to classify SCC and ADC. Finally, 7 types of classifiers were tested to achieve the optimized model for the classification: support vector machine (SVM) with linear kernel, SVM with radial basis function kernel (SVM-RBF), random forest, logistic regression, Gaussian process classifier, linear discriminant analysis, and the AdaBoost classifier. Furthermore, 5-fold cross-validation was applied to obtain the sensitivity, specificity, accuracy, and area under the curve (AUC) for performance evaluation.
RESULTS: Our model exhibited the best performance with the subregion radiomics features and SVM-RBF classifier, with a 5-fold cross-validation sensitivity, specificity, accuracy, and AUC of 0.8538, 0.8758, 0.8623, and 0.9155, respectively. The interquartile range feature from subregion 2 of CT and the gender feature from the clinical reports are the 2 optimized features that achieved the highest comprehensive score.
CONCLUSIONS: Our proposed model showed that SCC and ADC could be classified successfully using PET/CT images, which could be a promising tool to assist radiologists or medical physicists during diagnosis. The subregion-based method illustrated that non-small cell lung cancer (NSCLC) depicts intratumoral regional heterogeneity on both CT and PET images. By defining these heterogeneities through a subregion-based method, the diagnostic performance was improved. The 3D feature vector (whose basis is PET value, CT value, and CT local dominant orientation) showed superiority in reflecting NSCLC intratumoral regional heterogeneity. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Subregion-based radiomics; adenocarcinoma (ADC); non-small cell lung cancer (NSCLC); positron emission tomography/computed tomography (PET/CT); squamous cell carcinoma (SCC)

Year:  2021        PMID: 34249623      PMCID: PMC8250013          DOI: 10.21037/qims-20-1182

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  33 in total

Review 1.  Radiomics: the process and the challenges.

Authors:  Virendra Kumar; Yuhua Gu; Satrajit Basu; Anders Berglund; Steven A Eschrich; Matthew B Schabath; Kenneth Forster; Hugo J W L Aerts; Andre Dekker; David Fenstermacher; Dmitry B Goldgof; Lawrence O Hall; Philippe Lambin; Yoganand Balagurunathan; Robert A Gatenby; Robert J Gillies
Journal:  Magn Reson Imaging       Date:  2012-08-13       Impact factor: 2.546

Review 2.  The diagnosis of non-small cell lung cancer in the molecular era.

Authors:  Jennifer Brainard; Carol Farver
Journal:  Mod Pathol       Date:  2019-01-02       Impact factor: 7.842

Review 3.  Intratumor heterogeneity: evolution through space and time.

Authors:  Charles Swanton
Journal:  Cancer Res       Date:  2012-09-20       Impact factor: 12.701

4.  Computational Radiomics System to Decode the Radiographic Phenotype.

Authors:  Joost J M van Griethuysen; Andriy Fedorov; Chintan Parmar; Ahmed Hosny; Nicole Aucoin; Vivek Narayan; Regina G H Beets-Tan; Jean-Christophe Fillion-Robin; Steve Pieper; Hugo J W L Aerts
Journal:  Cancer Res       Date:  2017-11-01       Impact factor: 12.701

5.  Co-occurrence of Local Anisotropic Gradient Orientations (CoLlAGe): A new radiomics descriptor.

Authors:  Prateek Prasanna; Pallavi Tiwari; Anant Madabhushi
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

6.  Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence.

Authors:  Laurent Dercle; Samy Ammari; Mathilde Bateson; Paul Blanc Durand; Eva Haspinger; Christophe Massard; Cyril Jaudet; Andrea Varga; Eric Deutsch; Jean-Charles Soria; Charles Ferté
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

Review 7.  Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.

Authors:  Jie Lin; Guozhu Xie; Guixiang Liao; Baiyao Wang; Miaohong Yan; Hui Li; Yawei Yuan
Journal:  Oncotarget       Date:  2017-05-16

8.  Using CT texture analysis to differentiate between peripheral lung cancer and pulmonary inflammatory pseudotumor.

Authors:  Chenlu Liu; Changsheng Ma; Jinghao Duan; Qingtao Qiu; Yanluan Guo; Zhenhua Zhang; Yong Yin
Journal:  BMC Med Imaging       Date:  2020-07-06       Impact factor: 1.930

9.  The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.

Authors:  Alex Zwanenburg; Martin Vallières; Mahmoud A Abdalah; Hugo J W L Aerts; Vincent Andrearczyk; Aditya Apte; Saeed Ashrafinia; Spyridon Bakas; Roelof J Beukinga; Ronald Boellaard; Marta Bogowicz; Luca Boldrini; Irène Buvat; Gary J R Cook; Christos Davatzikos; Adrien Depeursinge; Marie-Charlotte Desseroit; Nicola Dinapoli; Cuong Viet Dinh; Sebastian Echegaray; Issam El Naqa; Andriy Y Fedorov; Roberto Gatta; Robert J Gillies; Vicky Goh; Michael Götz; Matthias Guckenberger; Sung Min Ha; Mathieu Hatt; Fabian Isensee; Philippe Lambin; Stefan Leger; Ralph T H Leijenaar; Jacopo Lenkowicz; Fiona Lippert; Are Losnegård; Klaus H Maier-Hein; Olivier Morin; Henning Müller; Sandy Napel; Christophe Nioche; Fanny Orlhac; Sarthak Pati; Elisabeth A G Pfaehler; Arman Rahmim; Arvind U K Rao; Jonas Scherer; Muhammad Musib Siddique; Nanna M Sijtsema; Jairo Socarras Fernandez; Emiliano Spezi; Roel J H M Steenbakkers; Stephanie Tanadini-Lang; Daniela Thorwarth; Esther G C Troost; Taman Upadhaya; Vincenzo Valentini; Lisanne V van Dijk; Joost van Griethuysen; Floris H P van Velden; Philip Whybra; Christian Richter; Steffen Löck
Journal:  Radiology       Date:  2020-03-10       Impact factor: 29.146

10.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

View more
  3 in total

1.  Immuno-PET imaging of PD-L1 expression in patient-derived lung cancer xenografts with [68Ga]Ga-NOTA-Nb109.

Authors:  Qingzhu Liu; Xiaodan Wang; Yanling Yang; Chao Wang; Jian Zou; Jianguo Lin; Ling Qiu
Journal:  Quant Imaging Med Surg       Date:  2022-06

Review 2.  Radiomics in Oncological PET Imaging: A Systematic Review-Part 1, Supradiaphragmatic Cancers.

Authors:  David Morland; Elizabeth Katherine Anna Triumbari; Luca Boldrini; Roberto Gatta; Daniele Pizzuto; Salvatore Annunziata
Journal:  Diagnostics (Basel)       Date:  2022-05-27

3.  A deep learning approach with subregion partition in MRI image analysis for metastatic brain tumor.

Authors:  Jiaxin Shi; Zilong Zhao; Tao Jiang; Hua Ai; Jiani Liu; Xinpu Chen; Yahong Luo; Huijie Fan; Xiran Jiang
Journal:  Front Neuroinform       Date:  2022-08-03       Impact factor: 3.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.